CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The RoNDBioCan project investigates the role of the NLRP3 inflammasome in non-small-cell lung cancer (NSCLC) to understand its molecular mechanisms and therapeutic potential. By studying NLRP3's involvement in DNA damage response and tumor suppression, the project aims to identify new treatment options for lung cancer…
Cancer represents one of the main causes of death in the European Union (WHO).
Particularly, non-small-cell lung cancer (NSCLC) accounts for 85% of lung cancers, and is the leading cause of cancer-related death worldwide.
Despite significant therapeutic improvements, the survival rate of patients with advanced stage NSCLC remains dismal, signifying a critical need to elucidate the molecular processes driving NSCLC.
Inflammasomes are major drivers of inflammatory responses and are deregulated in…
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
UNIVERSITE LYON 1 CLAUDE BERNARD
France, Villeurbanne Cedex
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
